NCT00003342

Tracking Information
First Received Date

  • November 1, 1999
Last Updated Date
Start Date
Estimated Primary Completion Date
Primary Outcome Measures
Secondary Outcome Measures
Descriptive Information
Brief Title
Official Title

  • Phase I Trial of Dose-Dense Gemcitabine, Doxorubicin, Then Paclitaxel Plus Carboplatin In Patients With Transitional Cell Carcinoma of the Urothelium and Impaired Renal Function
Detailed Description
Study Type
Study Phase
Study Design
Condition
Intervention
Study Arm (s)
References
Reqruitment Information
Recruitment Status
Estimated Enrollment
Estimated Primary Completion Date
Eligibility Criteria
Gender
Minimum Age
Maximum Age
Accepts Healthy Volunteers
Sampling Method
Contact(s)
Location Countries